ReutersAstraZeneca, Juno latest to collaborate on immuno-oncology drugsReuters(Reuters) - A unit of AstraZeneca Plc has teamed up with Juno Therapeutics Inc to develop combination treatments that use the body's immune system to kill cancer cells. The partnership between AstraZeneca's research and development arm MedImmune ...MedImmune, Juno Team Up to Study Cancer Immunotherapy ComboGenetic Engineering & Biotechnology News (blog)MedImmune and Juno Therapeutics Announce Immuno-Oncology Clinical Trial ...MarketWatchall 5 news articles »
AstraZeneca, Juno latest to collaborate on immuno
Rating: 4.5
Diposkan Oleh: Unknown
